474 related articles for article (PubMed ID: 18806055)
1. Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.
Grande LA; O'Donnell BR; Fitzgibbon DR; Terman GW
Anesth Analg; 2008 Oct; 107(4):1380-3. PubMed ID: 18806055
[TBL] [Abstract][Full Text] [Related]
2. Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management.
Suzuki M
Curr Opin Anaesthesiol; 2009 Oct; 22(5):618-22. PubMed ID: 19535974
[TBL] [Abstract][Full Text] [Related]
3. Ketamine combined with morphine for the management of cancer pain in a patient with meperidine tolerance and addiction.
Akin Takmaz S; Inan N; Günal S; Kaymak C; Sakalli M; Dikmen B
Agri; 2005 Jul; 17(3):44-7. PubMed ID: 16158342
[TBL] [Abstract][Full Text] [Related]
4. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
Finkel JC; Pestieau SR; Quezado ZM
J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
[TBL] [Abstract][Full Text] [Related]
5. Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: a case report.
Elsewaisy O; Slon B; Monagle J
Pain Med; 2010 Jun; 11(6):946-50. PubMed ID: 20624244
[TBL] [Abstract][Full Text] [Related]
6. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
Rabben T; Skjelbred P; Oye I
J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
[TBL] [Abstract][Full Text] [Related]
7. Interindividual differences in the analgesic response to ketamine in chronic orofacial pain.
Rabben T; Øye I
Eur J Pain; 2001; 5(3):233-40. PubMed ID: 11558979
[TBL] [Abstract][Full Text] [Related]
8. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
Amin P; Roeland E; Atayee R
J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
[TBL] [Abstract][Full Text] [Related]
9. Ketamine in cancer pain: an update.
Mercadante S
Palliat Med; 1996 Jul; 10(3):225-30. PubMed ID: 8817593
[TBL] [Abstract][Full Text] [Related]
10. Ketamine: an introduction for the pain and palliative medicine physician.
Okon T
Pain Physician; 2007 May; 10(3):493-500. PubMed ID: 17525784
[TBL] [Abstract][Full Text] [Related]
11. [Parenteral administration of low dose ketamine for the treatment of neuropathic pain in cancer patients].
Kong PE; Snijdelaar DG; Crul BJ
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2556-8. PubMed ID: 12532671
[TBL] [Abstract][Full Text] [Related]
12. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees.
Schley M; Topfner S; Wiech K; Schaller HE; Konrad CJ; Schmelz M; Birbaumer N
Eur J Pain; 2007 Apr; 11(3):299-308. PubMed ID: 16716615
[TBL] [Abstract][Full Text] [Related]
13. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements.
Kapural L; Kapural M; Bensitel T; Sessler DI
Pain Physician; 2010; 13(4):389-94. PubMed ID: 20648208
[TBL] [Abstract][Full Text] [Related]
14. [Ketamine infusion therapy for refractory neuralgia in spinal disease: report of two cases].
Matsuda W; Matsumura A; Enomoto T; Nose T; Suga A; Miyabe M; Toyooka H
No Shinkei Geka; 1999 Feb; 27(2):195-200. PubMed ID: 10065454
[TBL] [Abstract][Full Text] [Related]
15. Use of continuous intravenous ketamine for end-stage cancer pain in children.
Conway M; White N; Jean CS; Zempsky WT; Steven K
J Pediatr Oncol Nurs; 2009; 26(2):100-6. PubMed ID: 19202116
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of ketamine for analgesia.
Ben-Ari A; Lewis MC; Davidson E
J Pain Palliat Care Pharmacother; 2007; 21(1):7-14. PubMed ID: 17430824
[TBL] [Abstract][Full Text] [Related]
17. An intravenous ketamine test as a predictive response tool in opioid-exposed patients with persistent pain.
Cohen SP; Wang S; Chen L; Kurihara C; McKnight G; Marcuson M; Mao J
J Pain Symptom Manage; 2009 Apr; 37(4):698-708. PubMed ID: 18789637
[TBL] [Abstract][Full Text] [Related]
18. The use of ketamine as adjuvant therapy to control severe pain.
Campbell-Fleming JM; Williams A
Clin J Oncol Nurs; 2008 Feb; 12(1):102-7. PubMed ID: 18258579
[TBL] [Abstract][Full Text] [Related]
19. Managing chronic whiplash associated pain with a combination of low-dose opioid (remifentanil) and NMDA-antagonist (ketamine).
Lemming D; Sörensen J; Graven-Nielsen T; Lauber R; Arendt-Nielsen L; Gerdle B
Eur J Pain; 2007 Oct; 11(7):719-32. PubMed ID: 17197214
[TBL] [Abstract][Full Text] [Related]
20. Anti-allodynic interactions between NMDA receptor channel blockers and morphine or clonidine in neuropathic rats.
Malyshkin AA; Medvedev IO; Danysz W; Bespalov AY
Eur J Pharmacol; 2005 Sep; 519(1-2):80-5. PubMed ID: 16109402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]